Roche Pharma Research and Early Development (pRED)

Roche pRED transforms world-class science into medicine through a diversity of technologies and talent located across seven research sites worldwide.

Hear from the world-renowned scientists leading our research efforts across Roche pRED

Our organization consists of more than 2,200 scientists and clinicians working across the globe, from Europe to North America and Asia.

Our scientists have won a number of prestigious awards in recognition of major advances in biomedical research.

Our pipeline typically has 30 to 40 new molecular entities in development from Phase 0 to Phase II trials.